[Edaily Reporter KIM SAE-MI ] DIO Corporation (hereinafter “DIO”) is set to strengthen its global production system by commencing mass production at its JiaYang production base in China.
DIO Corporation(039840)The company announced on the 6th that it held a “Ceremony to Commemorate the Start of Mass Production at the Jiayang Production Base” in Jiayang City, Sichuan Province, China, on the 3rd, marking the full-scale launch of its local production system in China.
The event was held under the slogan “Beyond Borders, Quality Remains the Same” (世界无界，品質如一). It featured a ribbon-cutting ceremony, a plaque unveiling for the oral artificial intelligence (AI) laboratory, a tour of the production line, interviews with key officials, and a banquet. Attendees included representatives from the Chinese government and major local institutions, representatives from Korean organizations, clients, and DIO Corporation executives and employees.
The Ziyang production base is a key hub in DIO Corporation’s global production system, which is built around two main pillars: its headquarters in Busan, South Korea, and the Ziyang facility in China. Following the expansion of its Busan production base in April of this year, DIO Corporation has now commenced mass production at the Ziyang facility, thereby enhancing supply stability and market responsiveness for over 70 countries worldwide.
The Ziyang production base incorporates the manufacturing and production know-how and quality control systems that DIO Corporation has accumulated over 38 years. The entire production process—from computer numerical control (CNC), surface treatment, inspection, final cleaning, packaging, and gamma sterilization to warehousing—is operated using the same technology and quality standards as those at the South Korean headquarters. The company has also strengthened its production competitiveness by introducing state-of-the-art automated equipment and smart manufacturing systems.
Currently, the Jayang production facility has an annual production capacity of 750,000 units. This capacity can be expanded to a maximum of 3 million units in the future. The company expects this will enable it to respond more reliably to growing domestic and international demand. Mass production of its flagship product, the UFII implant, is scheduled to begin in earnest next month.
A plaque unveiling ceremony for the Oral AI Lab was also held during the event. The Oral AI Lab is an industry-academia-research collaboration project aimed at developing precise and efficient oral healthcare solutions by integrating AI, digital technology, and clinical data. Through this initiative, DIO Corporation plans to develop the Jiyang production base into a comprehensive innovation hub that combines smart manufacturing, AI R&D, and digital education, rather than simply serving as a production hub.
Kim Jong-won, CEO of DIO Corporation, stated, “The start of mass production at the Ziyang production base marks a significant turning point in DIO Corporation’s global strategy, going beyond a simple expansion of production.” He added, “By establishing a local production system, we will enhance supply stability and market responsiveness, and further strengthen our global competitiveness based on the Chinese market.”
